Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response

Abstract : Attenuated measles virus (MV) is currently being evaluated as an oncolytic virus in clinical trials and could represent a new therapeutic approach for malignant pleural mesothelioma (MPM). Herein, we screened the sensitivity to MV infection and replication of twenty-two human MPM cell lines and some healthy primary cells. We show that MV replicates in fifteen of the twenty-two MPM cell lines. Despite overexpression of CD46 by a majority of MPM cell lines compared to healthy cells, we found that the sensitivity to MV replication did not correlate with this overexpression. We then evaluated the antiviral type I interferon (IFN) responses of MPM cell lines and healthy cells. We found that healthy cells and the seven insensitive MPM cell lines developed a type I IFN response in presence of the virus, thereby inhibiting replication. In contrast, eleven of the fifteen sensitive MPM cell lines were unable to develop a complete type I IFN response in presence of MV. Finally, we show that addition of type I IFN onto MV sensitive tumor cell lines inhibits replication. These results demonstrate that defects in type I IFN response are frequent in MPM and that MV takes advantage of these defects to exert oncolytic activity. INTRODUCTION Antitumor virotherapy using oncolytic viruses is a developing strategy to treat cancer [1]. Among oncolytic viruses, attenuated strains of measles virus (MV) have been shown to infect and kill a large variety of tumor cell lines [2, 3]. Phase I clinical trials using the Edmonston strain of MV have shown clinical benefits for the treatment of cutaneous T cell lymphoma [4], ovarian cancer [5, 6] and disseminated multiple myeloma [1]. The Edmonston MV is also currently being evaluated in ongoing phase I clinical trials for the treatment of squamous cell carcinoma of the head and the neck, glioma and mesothelioma by the group of Stephen J. Russell at the Mayo Clinic [1]. Schwarz and Edmonston attenuated strains of MV use the CD46 molecule as the major receptor to infect human cells, unlike the pathogenic strains that mainly use the CD150 molecule [7-9]. The membrane cofactor protein CD46 is ubiquitously expressed at a low level by all nucleated cells and blocks the complement cascade at the C3 activation stage [10]. CD46 is often overexpressed on tumor cells of many cancer types to escape complement
Type de document :
Article dans une revue
Oncotarget, Impact journals, 2015
Liste complète des métadonnées

Littérature citée [36 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01285131
Contributeur : Elizabeth Bernardo <>
Soumis le : mardi 8 mars 2016 - 16:19:05
Dernière modification le : jeudi 17 mai 2018 - 12:00:32

Fichier

2015-C ACHARD-Oncotarget.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

  • HAL Id : inserm-01285131, version 1
  • PUBMED : 26539644

Collections

Citation

Carole Achard, Nicolas Boisgerault, Tiphaine Delaunay, David Roulois, Steven Nedellec, et al.. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response. Oncotarget, Impact journals, 2015. 〈inserm-01285131〉

Partager

Métriques

Consultations de la notice

207

Téléchargements de fichiers

69